Dutch Bros. Coffee
BROS
$67.03
-5.22%
Dutch Bros Inc. is a high-growth operator and franchisor of drive-thru coffee shops, primarily in the United States, focused on serving a wide variety of hand-crafted beverages. The company has established itself as a disruptive, experience-focused brand in the competitive restaurant industry, leveraging a cult-like following and a rapid unit expansion strategy to challenge established players. The current investor narrative is centered on a potential turnaround and re-acceleration story, as recent quarterly results have shown a significant rebound in revenue growth and profitability, contrasting with a period of significant stock price decline, which has sparked debate about whether the operational momentum justifies a re-rating.…
BROS
Dutch Bros. Coffee
$67.03
Related headlines
Investment Opinion: Should I buy BROS Today?
Rating & Thesis: Hold. Dutch Bros is a compelling growth story with strong operational momentum, but its extreme valuation premium and volatility necessitate a cautious stance, awaiting a better risk/reward entry point or confirmation of sustained execution. This aligns with the bullish analyst sentiment (Goldman Sachs Buy, Morgan Stanley Overweight) but tempers it with valuation discipline.
Supporting Evidence: The primary valuation metric, the forward P/E of 56.7x, is more than double the restaurant industry average. Revenue growth has impressively re-accelerated to 29.4% YoY in Q4 2025. Profitability is improving, with net income surging from $3.6M to $21.4M year-over-year in Q4. The stock also trades at a high Price/Sales of 4.68x and EV/Sales of 5.83x, further underscoring its premium pricing. The implied upside is uncertain without specific price targets, but the recent +34% monthly surge suggests the market is already pricing in much of the near-term optimism.
Risks & Conditions: The two biggest risks are valuation compression if growth decelerates below 20%, and extreme volatility (beta 2.37) magnifying losses in a down market. This Hold would upgrade to a Buy if the forward P/E compresses toward 40x without a deterioration in the 25%+ growth trajectory, or if same-store sales demonstrate sustained acceleration above current levels. It would downgrade to a Sell if revenue growth decelerates below 15% or if quarterly earnings miss estimates, signaling the growth story is faltering. Relative to its history and hyper-growth peers, the stock is overvalued, but fairly valued if one believes its unique growth profile can be maintained for several years.
Sign up to view all
BROS 12-Month Price Forecast
The 12-month outlook for BROS is a high-stakes balancing act between explosive growth potential and precarious valuation. The base case (50% probability) sees the stock range-bound as solid execution battles a rich multiple. The recent +34% monthly surge has likely front-run near-term optimism, limiting immediate upside. The stance is neutral due to the asymmetric risk/reward: the bull case offers ~20% upside to the 52-week high, while the bear case presents a >35% downside to the 52-week low. Confidence is medium because the limited analyst coverage (5 firms) increases forecast uncertainty. The stance would upgrade to bullish on evidence of sustained margin expansion above 10% or a valuation compression to a forward P/E below 45x without growth deterioration. It would downgrade to bearish on any quarterly growth deceleration below 15%.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Dutch Bros. Coffee's 12-month outlook, with a consensus price target around $87.14 and implied upside of +30.0% versus the current price.
Average Target
$87.14
5 analysts
Implied Upside
+30.0%
vs. current price
Analyst Count
5
covering this stock
Price Range
$54 - $87
Analyst target range
Analyst coverage for Dutch Bros is limited, with only 5 analysts providing estimates, indicating it is still a relatively new and niche story for institutional research. The consensus sentiment is bullish, as evidenced by recent institutional ratings from firms like Goldman Sachs (upgraded to Buy), Morgan Stanley (Overweight), and Barclays (Overweight). The average revenue estimate for the next period is $4.23 billion, with a high estimate of $4.33 billion and a low of $4.14 billion, while the average EPS estimate is $2.16. Specific price targets are not provided in the data, but the pattern of recent analyst actions suggests a positive bias. The limited number of covering analysts and the wide range of revenue estimates signal higher uncertainty and potential for volatile price discovery, which is typical for a high-growth, recently public company in a competitive sector.
Bulls vs Bears: BROS Investment Factors
The investment debate for Dutch Bros centers on whether its dramatic operational turnaround justifies its extreme valuation premium. Bullish evidence is currently stronger, anchored by the powerful re-acceleration of revenue growth to 29.4% YoY, explosive short-term price momentum (+34% in one month), and improving profitability. However, the bear case presents a formidable counter-argument based on valuation risk, with a forward P/E of 56.7x far exceeding industry norms, and extreme volatility (beta 2.37) that could punish shareholders during market downturns. The single most important tension is between the company's demonstrated hyper-growth trajectory and the market's demanding valuation expectations. The thesis hinges on whether BROS can consistently deliver 25%+ growth to grow into its multiples, or if any deceleration will trigger a severe valuation compression.
Bullish
- Revenue Growth Re-acceleration: Q4 2025 revenue grew 29.4% YoY to $443.6M, a dramatic acceleration from the 8.4% growth in Q1 2025. This sequential improvement from $355.2M to $443.6M demonstrates robust operational momentum driven by new shop openings and same-store sales.
- Explosive Short-Term Price Momentum: The stock has surged +34.02% over the past month and +41.44% over three months, with a 1-month relative strength of +33.28 against the S&P 500. This powerful reversal from a 52-week low of $44.58 signals a major sentiment shift, likely driven by strong quarterly results.
- Profitability and Margin Expansion: Q4 2025 net income of $21.37M represents a net margin of 4.8%, a significant improvement from $3.61M in Q4 2024. Operating margin of 7.66% and positive free cash flow of $54.41M TTM show the company is translating high growth into operating leverage and self-funding capability.
- Analyst Sentiment and Institutional Upgrades: Recent institutional actions include Goldman Sachs upgrading to Buy, Morgan Stanley maintaining Overweight, and Barclays at Overweight. This bullish consensus among major firms reflects confidence in the turnaround narrative and future growth estimates averaging $4.23B in revenue.
Bearish
- Extreme Valuation Premium: The stock trades at a trailing P/E of 96.1x and a forward P/E of 56.7x, a massive premium to the restaurant industry's typical 20x-30x forward P/E range. This valuation demands flawless execution of hyper-growth for years to justify, leaving no margin for error.
- Extreme Market Volatility (Beta 2.37): With a beta of 2.37, BROS is 137% more volatile than the broader market. This extreme sensitivity means the stock will experience amplified drawdowns during market corrections, as evidenced by its 52-week low of $44.58 being 40% below the current price.
- High Short Interest and Skepticism: A short ratio of 4.01 indicates significant bearish bets against the stock, reflecting market skepticism about the sustainability of its premium valuation and growth story. This creates potential for sharp downside on any operational misstep or growth deceleration.
- Limited Analyst Coverage and High Uncertainty: Only 5 analysts provide estimates, indicating BROS is still a niche, under-researched story. The wide range of revenue estimates ($4.14B low to $4.33B high) signals higher uncertainty and potential for volatile price discovery around earnings.
BROS Technical Analysis
The stock is in a pronounced downtrend over the past year, with a 1-year price change of only +1.27%, significantly underperforming the S&P 500's +24.99% gain. As of the latest close of $70.72, the stock is trading at approximately 87% of its 52-week high of $74.65, having recovered from its 52-week low of $44.58, indicating it is in the upper portion of its annual range but still below recent peaks. This positioning suggests the stock is attempting a recovery from deeply oversold levels, but faces significant resistance near its highs. Recent momentum has been exceptionally strong, with the stock surging +34.02% over the past month and +41.44% over the past three months, sharply diverging from its weak one-year performance. This explosive short-term rally, with a 1-month relative strength of +33.28 against the S&P 500, signals a powerful reversal attempt, likely driven by improved fundamentals and sentiment. Key technical levels are the 52-week low of $44.58, which now serves as major support, and the 52-week high of $74.65, which is the immediate resistance to watch for a breakout. The stock exhibits extreme volatility with a beta of 2.37, meaning it is approximately 137% more volatile than the broader market, which necessitates larger position sizing considerations for risk management.
Beta
2.37
2.37x market volatility
Max Drawdown
-37.1%
Largest decline past year
52-Week Range
$45-$75
Price range past year
Annual Return
-0.9%
Cumulative gain past year
| Period | BROS Return | S&P 500 |
|---|---|---|
| 1m | +28.6% | -0.2% |
| 3m | +27.3% | +14.0% |
| 6m | +4.6% | +7.8% |
| 1y | -0.9% | +25.3% |
| ytd | +7.8% | +9.2% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
BROS Fundamental Analysis
Revenue growth has re-accelerated impressively, with Q4 2025 revenue of $443.61 million representing a 29.4% year-over-year increase, a significant improvement from the 8.4% YoY growth in Q1 2025. This sequential acceleration, from $355.15M in Q1 to $443.61M in Q4, demonstrates robust top-line momentum, primarily driven by aggressive new shop openings and strong same-store sales. The company is profitable, with Q4 2025 net income of $21.37 million and a net margin of 4.8%, a substantial improvement from the $3.61 million net income in Q4 2024. Gross margin for the latest quarter was 24.15%, while operating margin stood at 7.66%, showing the company is translating high revenue growth into operating leverage. The balance sheet shows moderate leverage with a debt-to-equity ratio of 1.60, but the company maintains a healthy current ratio of 1.49. Free cash flow over the trailing twelve months is positive at $54.41 million, and the company generated $79.64 million in operating cash flow in Q4 2025, indicating an ability to fund its aggressive expansion internally. Return on equity of 11.73% is reasonable for a growth company, suggesting efficient use of shareholder capital.
Quarterly Revenue
$443610000.0B
2025-12
Revenue YoY Growth
+0.29%
YoY Comparison
Gross Margin
+0.24%
Latest Quarter
Free Cash Flow
$54411000.0B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is BROS Overvalued?
Given the company's positive net income, the primary valuation metric is the P/E ratio. The trailing P/E is extremely high at 96.1x, while the forward P/E is 56.7x, indicating the market is pricing in significant future earnings growth, with the forward multiple implying an expected near-doubling of earnings. Compared to the restaurant industry, which typically trades at forward P/Es in the 20x-30x range, Dutch Bros trades at a substantial premium, justified only by its hyper-growth profile. The stock also trades at a Price/Sales ratio of 4.68x and an EV/Sales of 5.83x. Historically, the stock's own trailing P/E has ranged from deeply negative during its early unprofitable quarters to over 400x during its IPO phase, settling recently between 80x-120x. The current trailing P/E of 96.1x sits near the middle of its own post-IPO historical range, suggesting the market is currently pricing in a continuation of its recent profitability improvement but remains skeptical of peak multiples seen earlier.
PE
95.7x
Latest Quarter
vs. Historical
High-End
5-Year PE Range -588x~416x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
40.4x
Enterprise Value Multiple
Investment Risk Disclosure
Financial & Operational Risks: Dutch Bros carries significant financial risk from its premium valuation, which is entirely dependent on sustained hyper-growth. The forward P/E of 56.7x implies the market expects near-doubling of earnings; any miss on the $2.16 average EPS estimate could trigger a sharp de-rating. While the company has improved profitability with a 4.8% net margin and positive $54.4M TTM free cash flow, its debt-to-equity ratio of 1.60 indicates moderate leverage that could pressure finances if expansion costs rise or same-store sales falter. Revenue concentration in company-operated shops (the primary segment) creates operational risk if new unit openings slow or cannibalization occurs.
Market & Competitive Risks: The stock faces severe valuation compression risk, trading at a ~2x premium to typical restaurant forward P/Es. With a beta of 2.37, it is hypersensitive to market rotations away from growth stocks, particularly if interest rates remain elevated. Competitive disruption from established players like Starbucks and newer entrants threatens market share in the fragmented coffee segment. Recent news highlights the narrative of 'superior growth potential vs. stability,' but this also sets high expectations that must be continually met. Sector rotation risk is elevated given its classification as a high-growth, high-multiple consumer cyclical stock.
Worst-Case Scenario: The worst-case scenario involves a combination of growth deceleration and multiple compression. If same-store sales growth falters and new shop openings disappoint, leading to a revenue miss against the $4.23B estimate, analyst downgrades could follow. Concurrently, a broader market correction targeting high-multiple stocks could trigger a flight to safety. This could realistically drive the stock back to its 52-week low of $44.58, representing a -37% decline from the current ~$70.72 level, matching its historical max drawdown of -37.11%. An investor could lose over a third of their capital in this adverse scenario, exacerbated by the high short interest fueling downward momentum.
FAQ
The key risks are, in order of severity: 1) Valuation Compression: The extreme forward P/E of 56.7x leaves the stock vulnerable to a sharp decline if growth decelerates. 2) Extreme Volatility: With a beta of 2.37, the stock is 137% more volatile than the market, magnifying losses during downturns. 3) Execution Risk: The aggressive expansion strategy could falter due to competition, cannibalization, or rising costs, hurting same-store sales and margins. 4) Sentiment Risk: High short interest (ratio 4.01) and limited analyst coverage (only 5 firms) can lead to exaggerated price swings on news. 5) Macro Risk: As a consumer cyclical stock, it is sensitive to reductions in discretionary spending.
The 12-month forecast presents three scenarios. The Base Case (50% probability) sees the stock trading between $65 and $74.65, assuming it meets analyst estimates for ~$4.23B revenue and $2.16 EPS. The Bull Case (30% probability) targets $74.65 to $85, requiring sustained >25% growth and a market re-rating. The Bear Case (20% probability) warns of a drop to $44.58-$55 if growth stalls, triggering valuation compression. The Base Case is most likely, anchored by the company's recent operational momentum but constrained by its high valuation. The key assumption is that revenue growth remains above 20%.
BROS is overvalued based on traditional restaurant industry metrics but may be fairly valued if its hyper-growth trajectory is sustained. The forward P/E of 56.7x is more than double the typical restaurant industry range of 20x-30x. Its Price/Sales ratio of 4.68x and EV/Sales of 5.83x are also at a premium. Historically, its own trailing P/E of 96.1x sits in the middle of its post-IPO range. The valuation implies the market expects near-doubling of earnings and sustained >25% revenue growth for the foreseeable future. Any deviation from this growth path will likely trigger significant multiple compression.
BROS is a good buy only for aggressive growth investors with a high risk tolerance and a long-term horizon who believe the company can sustain its 25%+ revenue growth for several years. The stock offers a compelling turnaround story with 29.4% YoY growth and improving margins, but it carries severe risks: a lofty forward P/E of 56.7x, extreme volatility (beta 2.37), and high short interest (ratio 4.01). For most investors, it is currently a Hold, as the recent +34% monthly surge has priced in much of the near-term optimism, making the risk/reward more balanced. A better entry point may emerge if the valuation compresses during a market pullback.
BROS is strictly suitable for long-term investment (minimum 3-5 years) due to its high-growth, high-volatility profile. The company is in an aggressive expansion phase, and the investment thesis hinges on successful national rollout and scaling of profitability over many years. Its extreme beta of 2.37 and lack of dividend make it a poor candidate for short-term trading, as unpredictable volatility can quickly erase gains. Long-term investors can potentially ride out the volatility to capture the growth story, but they must be prepared for significant drawdowns along the way. Short-term traders should avoid it unless they specialize in high-risk, momentum-driven names.